Do analysts prefer AVNS or SNAL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Snail 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is AVNS or SNAL more profitable?

Snail has a net margin of -8.83% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity. Company Net Margins Return on Equity Return on Assets Avanos Medical -10.39% 5.39% 3.97% Snail -8.83% -15.49% -13.52%

Do analysts recommend AVNS or NVST?

Envista has a consensus target price of $29.86, indicating a potential upside of 27.70%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Envista 0 Sell rating(s) 9 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.53

Which has preferable valuation and earnings, AVNS or NVST?

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A Envista $2.72B 1.38 $47M $0.58 40.31

Do analysts prefer ICUI or AVNS?

ICU Medical presently has a consensus target price of $192.80, indicating a potential upside of 26.30%. Given ICU Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe ICU Medical is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ICU Medical 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.89 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has better valuation & earnings, ICUI or AVNS?

ICU Medical has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ICU Medical $2.16B 1.77 $730K $1.18 129.36 Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A

Do analysts recommend AVNS or NEOG?

Neogen has a consensus target price of $12.00, suggesting a potential downside of 7.69%. Given Neogen's stronger consensus rating and higher possible upside, analysts clearly believe Neogen is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Neogen 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has better earnings & valuation, AVNS or NEOG?

Neogen has higher revenue and earnings than Avanos Medical. Neogen is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A Neogen $870.40M 3.26 -$7.90M -$0.03 N/A

Is AVNS or NEOG more profitable?

Neogen has a net margin of -0.91% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets Avanos Medical -10.39% 5.39% 3.97% Neogen -0.91% 2.78% 1.74%

Do analysts recommend AVNS or XRAY?

DENTSPLY SIRONA has a consensus target price of $13.31, indicating a potential upside of 39.49%. Given DENTSPLY SIRONA's stronger consensus rating and higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 DENTSPLY SIRONA 3 Sell rating(s) 9 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.00

Avanos Medical (AVNS) Competitors

$24.99 0.00 (0.00%)

As of 09/18/2026

Compare

AVNS vs. SNAL, NVST, ICUI, NEOG, and XRAY

Should you buy Avanos Medical stock or one of its competitors? Avanos Medical's main competitors and comparable companies include Snail (SNAL), Envista (NVST), ICU Medical (ICUI), Neogen (NEOG), and DENTSPLY SIRONA (XRAY). Companies are selected based on similarities in market, industry, and size.

How does Avanos Medical compare to Snail?

Avanos Medical (NYSE:AVNS) and Snail (NASDAQ:SNAL) are related small-cap companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Snail	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Snail has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
Snail	$81.23M	0.28	-$27.24M	-$1.26	N/A

In the previous week, Snail had 5 more articles in the media than Avanos Medical. MarketBeat recorded 5 mentions for Snail and 0 mentions for Avanos Medical. Snail's average media sentiment score of 0.23 beat Avanos Medical's score of 0.00 indicating that Snail is being referred to more favorably in the news media.

Company	Overall Sentiment
Avanos Medical	Neutral
Snail	Neutral

Snail has a net margin of -8.83% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Snail	-8.83%	-15.49%	-13.52%

Avanos Medical has a beta of 1.57, suggesting that its share price is 57% more volatile than the broader market. Comparatively, Snail has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market.

95.2% of Avanos Medical shares are held by institutional investors. Comparatively, 0.4% of Snail shares are held by institutional investors. 2.3% of Avanos Medical shares are held by company insiders. Comparatively, 66.8% of Snail shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Snail beats Avanos Medical on 9 of the 15 factors compared between the two stocks.

How does Avanos Medical compare to Envista?

Avanos Medical (NYSE:AVNS) and Envista (NYSE:NVST) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

95.2% of Avanos Medical shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by insiders. Comparatively, 1.0% of Envista shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
Envista	$2.72B	1.38	$47M	$0.58	40.31

Envista has a consensus target price of $29.86, indicating a potential upside of 27.70%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Envista	0 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.53

Avanos Medical has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

In the previous week, Envista had 18 more articles in the media than Avanos Medical. MarketBeat recorded 18 mentions for Envista and 0 mentions for Avanos Medical. Envista's average media sentiment score of 0.52 beat Avanos Medical's score of 0.00 indicating that Envista is being referred to more favorably in the news media.

Company	Overall Sentiment
Avanos Medical	Neutral
Envista	Positive

Envista has a net margin of 3.33% compared to Avanos Medical's net margin of -10.39%. Envista's return on equity of 7.88% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Envista	3.33%	7.88%	4.33%

Summary

Envista beats Avanos Medical on 13 of the 17 factors compared between the two stocks.

How does Avanos Medical compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and Avanos Medical (NYSE:AVNS) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

ICU Medical has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.16B	1.77	$730K	$1.18	129.36
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

ICU Medical presently has a consensus target price of $192.80, indicating a potential upside of 26.30%. Given ICU Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe ICU Medical is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

ICU Medical has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market.

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 95.2% of Avanos Medical shares are held by institutional investors. 2.1% of ICU Medical shares are held by insiders. Comparatively, 2.3% of Avanos Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, ICU Medical had 8 more articles in the media than Avanos Medical. MarketBeat recorded 8 mentions for ICU Medical and 0 mentions for Avanos Medical. ICU Medical's average media sentiment score of 0.65 beat Avanos Medical's score of 0.00 indicating that ICU Medical is being referred to more favorably in the media.

Company	Overall Sentiment
ICU Medical	Positive
Avanos Medical	Neutral

ICU Medical has a net margin of 1.39% compared to Avanos Medical's net margin of -10.39%. ICU Medical's return on equity of 7.91% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	1.39%	7.91%	4.17%
Avanos Medical	-10.39%	5.39%	3.97%

Summary

ICU Medical beats Avanos Medical on 15 of the 17 factors compared between the two stocks.

How does Avanos Medical compare to Neogen?

Avanos Medical (NYSE:AVNS) and Neogen (NASDAQ:NEOG) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

Neogen has higher revenue and earnings than Avanos Medical. Neogen is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
Neogen	$870.40M	3.26	-$7.90M	-$0.03	N/A

Neogen has a consensus target price of $12.00, suggesting a potential downside of 7.69%. Given Neogen's stronger consensus rating and higher possible upside, analysts clearly believe Neogen is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Neogen	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Neogen has a net margin of -0.91% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Neogen	-0.91%	2.78%	1.74%

Avanos Medical has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market. Comparatively, Neogen has a beta of 1.76, meaning that its stock price is 76% more volatile than the broader market.

95.2% of Avanos Medical shares are held by institutional investors. Comparatively, 96.7% of Neogen shares are held by institutional investors. 2.3% of Avanos Medical shares are held by insiders. Comparatively, 0.5% of Neogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Neogen had 11 more articles in the media than Avanos Medical. MarketBeat recorded 11 mentions for Neogen and 0 mentions for Avanos Medical. Neogen's average media sentiment score of 0.45 beat Avanos Medical's score of 0.00 indicating that Neogen is being referred to more favorably in the news media.

Company	Overall Sentiment
Avanos Medical	Neutral
Neogen	Neutral

Summary

Neogen beats Avanos Medical on 12 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to DENTSPLY SIRONA?

Avanos Medical (NYSE:AVNS) and DENTSPLY SIRONA (NASDAQ:XRAY) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

In the previous week, DENTSPLY SIRONA had 6 more articles in the media than Avanos Medical. MarketBeat recorded 6 mentions for DENTSPLY SIRONA and 0 mentions for Avanos Medical. DENTSPLY SIRONA's average media sentiment score of 0.16 beat Avanos Medical's score of 0.00 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.

Company	Overall Sentiment
Avanos Medical	Neutral
DENTSPLY SIRONA	Neutral

Avanos Medical has a net margin of -10.39% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
DENTSPLY SIRONA	-14.99%	20.84%	5.32%

Avanos Medical has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market.

DENTSPLY SIRONA has a consensus target price of $13.31, indicating a potential upside of 39.49%. Given DENTSPLY SIRONA's stronger consensus rating and higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Avanos Medical has higher earnings, but lower revenue than DENTSPLY SIRONA. Avanos Medical is trading at a lower price-to-earnings ratio than DENTSPLY SIRONA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
DENTSPLY SIRONA	$3.68B	0.52	-$598M	-$2.75	N/A

Summary

DENTSPLY SIRONA beats Avanos Medical on 10 of the 16 factors compared between the two stocks.

Get Avanos Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVNS vs. The Competition

Export

Metric	Avanos Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.17B	$5.52B	$7.26B	$23.17B
Dividend Yield	N/A	1.79%	2.57%	3.59%
P/E Ratio	-15.52	25.11	275.22	28.21
Price / Sales	1.64	72.24	694.52	20.34
Price / Cash	7.30	32.72	77.42	34.53
Price / Book	1.49	5.69	10.46	4.67
Net Income	-$72.90M	$151.55M	$3.49B	$1.07B
7 Day Performance	N/A	0.66%	0.60%	-1.64%
1 Month Performance	N/A	-3.83%	-2.01%	-4.25%
1 Year Performance	109.65%	6.86%	18.09%	8.32%

Avanos Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVNS Avanos Medical	N/A	$24.99 flat	N/A	N/A	$1.17B	$715.90M	N/A	4,040	Positive News
SNAL Snail	1.6646 of 5 stars	$2.58 +1.8%	N/A	-48.4%	$23.03M	$81.23M	N/A	60	Short Interest Decrease
NVST Envista	3.4804 of 5 stars	$26.76 -1.9%	$29.71 +11.1%	+11.2%	$4.31B	$2.72B	46.24	12,000	Trending News Analyst Forecast
ICUI ICU Medical	3.8586 of 5 stars	$162.37 -3.1%	$192.80 +18.7%	+14.8%	$4.06B	$2.23B	137.81	13,000
NEOG Neogen	1.7086 of 5 stars	$11.93 +0.8%	$12.00 +0.6%	+129.3%	$2.61B	$870.40M	N/A	2,110

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AVNS) was last updated on 9/19/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, NVST, ICUI, NEOG, and XRAY

How does Avanos Medical compare to Snail?

Summary

How does Avanos Medical compare to Envista?

Summary

How does Avanos Medical compare to ICU Medical?

Summary

How does Avanos Medical compare to Neogen?

Summary

How does Avanos Medical compare to DENTSPLY SIRONA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, NVST, ICUI, NEOG, and XRAY

How does Avanos Medical compare to Snail?

Do analysts prefer AVNS or SNAL?

Which has preferable earnings & valuation, AVNS or SNAL?

Does the media refer more to AVNS or SNAL?

Is AVNS or SNAL more profitable?

Which has more volatility and risk, AVNS or SNAL?

Do institutionals and insiders believe in AVNS or SNAL?

Summary

How does Avanos Medical compare to Envista?

Do institutionals & insiders believe in AVNS or NVST?

Which has preferable valuation and earnings, AVNS or NVST?

Do analysts recommend AVNS or NVST?

Which has more volatility and risk, AVNS or NVST?

Does the media refer more to AVNS or NVST?

Is AVNS or NVST more profitable?

Summary

How does Avanos Medical compare to ICU Medical?

Which has better valuation & earnings, ICUI or AVNS?

Do analysts prefer ICUI or AVNS?

Which has more volatility & risk, ICUI or AVNS?

Do institutionals & insiders believe in ICUI or AVNS?

Does the media prefer ICUI or AVNS?

Is ICUI or AVNS more profitable?

Summary

How does Avanos Medical compare to Neogen?

Which has better earnings & valuation, AVNS or NEOG?

Do analysts recommend AVNS or NEOG?

Is AVNS or NEOG more profitable?

Which has more volatility and risk, AVNS or NEOG?

Do insiders and institutionals hold more shares of AVNS or NEOG?

Does the media favor AVNS or NEOG?

Summary

How does Avanos Medical compare to DENTSPLY SIRONA?

Does the media refer more to AVNS or XRAY?

Is AVNS or XRAY more profitable?

Which has more volatility & risk, AVNS or XRAY?

Do analysts recommend AVNS or XRAY?

Do institutionals and insiders believe in AVNS or XRAY?

Which has higher earnings & valuation, AVNS or XRAY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools